Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28331617
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Immunother+Cancer
2017 ; 5
(ä): 28
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Current approaches to increase CAR T cell potency in solid tumors: targeting the
tumor microenvironment
#MMPMID28331617
Scarfò I
; Maus MV
J Immunother Cancer
2017[]; 5
(ä): 28
PMID28331617
show ga
Chimeric antigen receptor (CAR) T-cell therapy represents a revolutionary
treatment for haematological malignancies (i.e. B-ALL). However, the success of
this type of treatment has not yet been achieved in solid tumors. One hypothesis
is that the immunosuppressive nature of the tumor microenvironment (TME)
influences and affects the efficacy of adoptive immunotherapy. Understanding the
role of the TME and its interaction with CAR T-cells is crucial to improve the
potency of adoptive immunotherapy. In this review, we discuss the strategies and
potential combinatorial approaches recently developed in mouse models to enhance
the efficacy of CAR T-cells, with particular emphasis on the translational
potential of these approaches.